ADAR1 Capital Management »

Praxis Precision Medicines I shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $442k 1.5k 294.74

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Praxis Precision Medicines I

Henderson Group
Adage Capital Partners GP
BlackRock
Perceptive Advisors
Vanguard Group
Orbis Allan Gray
Point72 Asset Management
Cormorant Asset Management
Deerfield Management Company
State Street Corporation
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Barclays
Driehaus Capital Management

View all funds holding Praxis Precision Medicines I